PACS Group (NYSE:PACS) Earns Buy Rating from Analysts at Truist Financial

Truist Financial began coverage on shares of PACS Group (NYSE:PACSFree Report) in a report released on Monday, MarketBeat reports. The firm issued a buy rating and a $32.00 target price on the stock.

Separately, Royal Bank of Canada started coverage on PACS Group in a report on Monday. They issued an outperform rating and a $30.00 price objective on the stock. Six analysts have rated the stock with a buy rating, According to MarketBeat.com, the company currently has an average rating of Buy and an average price target of $30.50.

Read Our Latest Report on PACS Group

PACS Group Price Performance

PACS opened at $24.93 on Monday. PACS Group has a one year low of $22.61 and a one year high of $25.72.

Insider Buying and Selling at PACS Group

In other PACS Group news, CEO Jason Hulse Murray sold 1,607,142 shares of the business’s stock in a transaction that occurred on Monday, April 15th. The stock was sold at an average price of $21.00, for a total value of $33,749,982.00. Following the sale, the chief executive officer now owns 62,754,551 shares of the company’s stock, valued at $1,317,845,571. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

PACS Group Company Profile

(Get Free Report)

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

Read More

Analyst Recommendations for PACS Group (NYSE:PACS)

Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.